The metabolomic profiling of serum in rats exposed to arsenic using UPLC/Q-TOF MS

Toxicology Letters

Volumn 229, Issue 3, 2014, Pages 474-481

  Wang, Cheng ^a   Feng, Rennan ^a   Li, Yuanyuan ^a   Zhang, Yunbo ^a   Kang, Zhen ^b   Zhang, Wei ^a   Sun, Dian Jun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Biomarker; Chronic arsenicosis; Mechanism; Metabonomics

Indexed keywords

BIOMARKER; CHRONIC ARSENICOSIS; MECHANISM; METABONOMICS;

ANIMALS; ARSENIC POISONING; ARSENITES; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MASS SPECTROMETRY; METABOLOMICS; RATS; RATS, WISTAR;

EID: 84905402844     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.06.001     Document Type: Article

References (35)

1. Bashir S., Sharma Y., Irshad M., Nag T.C., Tiwari M., Kabra M., Dogra T.D. Arsenic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology 2006, 217(1):63-70.
2. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 2002, 54(2):265-269.
3. Demers L.M., Hepner G.W. Levels of immunoreactive glycine-conjugated bile acids in health and hepatobiliary disease. Am. J. Clin. Pathol. 1976, 66(5):831-839.
4. Dettmer K., Aronov P.A., Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 2007, 26(1):51-78.
5. Eriksson L., Johansson E., Kettaneh-Wold N., Wold S. Multi- and Megavariate Data Analysis: Principles and Applications 2001, Umetrics, Umeå.
6. Fischer D.J., Liliom K., Guo Z., Nusser N., Virág T., Murakami-Murofushi K., Kobayashi S., Erickson J.R., Sun G., Miller D.D., Tigyi G. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes. Mol. Pharmacol. 1998, 54(6):979-988.
7. Goñi F.M., Requero M.A., Alonso A. Palmitoylcarnitine, a surface-active metabolite. FEBS Lett. 1996, 390(1):1-5.
8. Griffin J.L., Walker L.A., Shore R.F., Shore J.K., Nicholson J.K. Metabolic profiling of chronic cadmium exposure in the rat. Chem. Res. Toxicol. 2001, 14(10):1428-1434.
9. Haruna T., Horie M., Takano M., Kono Y., Yoshida H., Otani H., Kubota T., Ninomiya T., Akao M., Sasayama S. Alteration of the membrane lipid environment by l-palmitoylcarnitine modulates K(ATP) channels in guinea-pig ventricular myocytes. Pflugers Arch. 2000, 441(2-3):200-207.
10. Huang M., Choi S.J., Kim D.W., Kim N.Y., Park C.H., Yu S.D., Kim D.S., Park K.S., Song J.S., Kim H., Choi B.S., Yu I.J., Park J.D. Risk assessment of low level cadmium and arsenic on the kidney. J. Toxicol. Environ. Health A 2009, 72(21-22):1493-1498.
11. Khurana S., Raina H., Pappas V., Raufman J.P., Pallone T.L. Effects of deoxycholylglycine, a conjugated secondary bile acid, on myogenic tone and agonist-induced contraction in rat resistance arteries. PLoS One 2012, 7(2):e32006.
12. Kobayashi T., Tanaka-Ishii R., Taguchi R., Ikezawa H., Murakami-Murofushi K. Existence of a bioactive lipid, cyclic phosphatidic acid, bound to human serum albumin. Life Sci. 1999, 65(21):2185-2191.
13. Lenz E.M., Wilson I.D. Analytical strategies in metabonomics. J. Proteome. Rev. 2007, 6(2):443-458.
14. Liu J., Liu Y., Goyer R.A., Achanzar W., Waalkes M.P. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol. Sci. 2000, 55(2):460-467.
15. Majhi C.R., Khan S., Leo M.D., Manimaran A., Sankar P., Sarkar S.N. Effects of acetaminophen on reactive oxygen species and nitric oxide redox signaling in kidney of arsenic-exposed rats. Food Chem. Toxicol. 2011, 49(4):974-982.
16. Meyer zu Heringdorf D., Jakobs K.H. Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism. Biochim. Biophys. Acta 2007, 1768(4):923-940.
17. Murakami-Murofushi K., Kobayashi S., Onimura K., Matsumoto M., Shioda M., Yoshida S., Shoji M., Murofushi H. Selective inhibition of DNA polymerase-alpha family with chemically synthesized derivatives of PHYLPA, a unique Physarum lysophosphatidic acid. Biochim. Biophys. Acta 1995, 1258(1):57-60.
18. Nałecz K.A., Miecz D., Berezowski V., Cecchelli R. Carnitine: transport and physiological functions in the brain. Mol. Aspects Med. 2004, 25(5-6):551-567.
19. Namgung U., Xia Z. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol. Appl. Pharmacol. 2001, 174(2):130-138.
20. Nicholls A.W., Holmes E., Lindon J.C., Shockcor J.P., Farrant R.D., Haselden J.N., Damment S.J., Waterfield C.J., Nicholson J.K. Metabonomic investigations into hydrazine toxicity in the rat. Chem. Res. Toxicol. 2001, 14(8):975-987.
21. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29(11):1181-1189.
22. Nicholson J.K., Wilson I.D. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog. Nucl. Magn. Reson. Spectrosc. 1989, 21(4):449-501.
23. Nicholson J.K., Wilson I.D. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2003, 2(8):668-676.
24. Park K.S., Lee H.Y., Lee S.Y., Kim M.K., Kim S.D., Kim J.M., Yun J., Im D.S., Bae Y.S. Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: Involvement of pertussis toxin-sensitive G-protein coupled receptor. FEBS Lett. 2007, 581(23):4411-4416.
25. Pham H., Banerjee T., Nalbandian G.M., Ziboh V.A. Activation of peroxisome proliferator-activated receptor (PPAR)-gamma by 15S-hydroxyeicosatrienoic acid parallels growth suppression of androgen-dependent prostatic adenocarcinoma cells. Cancer Lett. 2003, 189(1):17-25.
26. Pham H., Banerjee T., Ziboh V.A. Suppression of cyclooxygenase-2 overexpression by 15S-hydroxyeicosatrienoic acid in androgen-dependent prostatic adenocarcinoma cells. Int. J. Cancer 2004, 111(2):192-197.
27. Rosca M.G., Vazquez E.J., Chen Q., Kerner J., Kern T.S., Hoppel C.L. Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 2012, 61(8):2074-2083.
28. Szczepankowska D., Nałecz K.A. Palmitoylcarnitine modulates palmitoylation of proteins: implication for differentiation of neural cells. Neurochem. Res. 2003, 28(3-4):645-651.
29. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 2001, 176(2):127-144.
30. USA Today, 2007. Arsenic in drinking water seen as threat. (accessed 04.03.13). http://usatoday30.usatoday.com/news/world/2007-08-30-553404631_x.htm.
31. Wang J., Zhang W., Sun D.J., Song L., Li Y.Y., Xu C.B. Analysis of neuroglobin mRNA expression in rat Brain due to arsenite-induced oxidative stress. Environ. Toxicol. 2012, 27(9):503-509.
32. Watanabe H., Kobayashi A., Hayashi H., Yamazaki N. Effects of long-chain acyl carnitine on membrane fluidity of human erythrocytes. Biochim. Biophys. Acta 1989, 980(3):315-318.
33. Watanabe T., Hirano S. Metabolism of arsenic and its toxicological relevance. Arch. Toxicol. 2013, 87(6):969-979.
34. WHO, 1981. Arsenic. Environmental Health Criteria 18. Geneva: lnternational Programme on Chemical Safety. (accessed 04.03.13). http://www.inchem.org/documents/ehc/ehc/ehc018.htm.
35. Yang J., Xu G., Hong Q., Liebich H.M., Lutz K., Schmülling R.M., Wahl H.G. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 813(1):53-58.